Skip to content
2000
  1. Home
  2. A-Z Publications
  3. Current Neuropharmacology
  4. Fast Track Articles
  5. Fast Track Article
image of Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats

Abstract

This review explores the therapeutic potential of the stable gastric pentadecapeptide BPC 157 in addressing electrolyte imbalances, specifically hyperkalemia, hypokalemia, hypermagnesemia, and hyperlithemia. In hyperkalemia, BPC 157 demonstrated a comprehensive counteractive effect against KCl overdose (intraperitoneally, intragastrically, and ), effectively mitigating symptoms such as muscular weakness, hypertension, sphincter dysfunction, arrhythmias, and lethality. It also counteracted the adverse effects of succinylcholine and magnesium overdose, including systemic muscle paralysis, arrhythmias, and hyperkalemia. In hypokalemia, BPC 157 (administered prophylactically or therapeutically, intraperitoneally or intragastrically) prevented fatal outcomes and addressed furosemide-induced hypokalemia, ECG changes, AV conduction block, ventricular arrhythmias, and skeletal muscle myoclonus. Following magnesium overdose, BPC 157 alleviated muscle weakness, brain lesions, and hyperkalemia-induced complications. studies (HEK293 cells) revealed the ability of BPC 157 to counteract hyperkalemia- and hypermagnesemia-induced depolarization and hypokalemia-induced hyperpolarization. In lithium intoxication, BPC 157 promoted collateral pathway activation, resolved vascular and multiorgan failure, and counteracted advanced Virchow triad conditions and occlusion-like syndromes. Collectively, these findings underscore the therapeutic promise of BPC 157 in managing electrolyte imbalances and warrant further investigation.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cn/10.2174/011570159X349612241205065330
2025-01-24
2025-03-27

  • From This Site

    /content/journals/cn/10.2174/011570159X349612241205065330
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Sikiric P. Gojkovic S. Knezevic M. Tepes M. Strbe S. Vukojevic J. Duzel A. Kralj T. Krezic I. Zizek H. Oroz K. Vranes H. Smoday I.M. Kalogjera L. Vlainic J. Kokot A. Jurjevic I. Blagaic A.B. Skrtic A. Seiwerth S. Stable gastric pentadecapeptide BPC 157: Prompt particular activation of collateral pathways. Curr. Med. Chem. 2023 30 13 1568 1573 10.2174/0929867329666221005111553 36200148
    [Google Scholar]
  2. Sikiric P. Gojkovic S. Krezic I. Smoday I.M. Kalogjera L. Zizek H. Oroz K. Vranes H. Vukovic V. Labidi M. Strbe S. Baketic Oreskovic L. Sever M. Tepes M. Knezevic M. Barisic I. Blagaic V. Vlainic J. Dobric I. Staresinic M. Skrtic A. Jurjevic I. Boban Blagaic A. Seiwerth S. Stable gastric pentadecapeptide BPC 157 may recover brain-gut axis and gut-brain axis function. Pharmaceuticals 2023 16 5 676 10.3390/ph16050676 37242459
    [Google Scholar]
  3. Sikiric P. Boban Blagaic A. Strbe S. Beketic Oreskovic L. Oreskovic I. Sikiric S. Staresinic M. Sever M. Kokot A. Jurjevic I. Matek D. Coric L. Krezic I. Tvrdeic A. Luetic K. Batelja Vuletic L. Pavic P. Mestrovic T. Sjekavica I. Skrtic A. Seiwerth S. The stable gastric pentadecapeptide BPC 157 pleiotropic beneficial activity and its possible relations with neurotransmitter activity. Pharmaceuticals 2024 17 4 461 10.3390/ph17040461 38675421
    [Google Scholar]
  4. Staresinic M. Japjec M. Vranes H. Prtoric A. Zizek H. Krezic I. Gojkovic S. Smoday I.M. Oroz K. Staresinic E. Dretar V. Yago H. Milavic M. Sikiric S. Lovric E. Batelja Vuletic L. Simeon P. Dobric I. Strbe S. Kokot A. Vlainic J. Blagaic A.B. Skrtic A. Seiwerth S. Sikiric P. Stable gastric pentadecapeptide BPC 157 and striated, smooth, and heart muscle. Biomedicines 2022 10 12 3221 10.3390/biomedicines10123221 36551977
    [Google Scholar]
  5. Sikiric P. Udovicic M. Barisic I. Balenovic D. Zivanovic Posilovic G. Strinic D. Uzun S. Sikiric S. Krezic I. Zizek H. Yago H. Gojkovic S. Smoday I.M. Kalogjera L. Vranes H. Sola M. Strbe S. Koprivanac A. Premuzic Mestrovic I. Mestrovic T. Pavic P. Skrtic A. Blagaic A.B. Lovric Bencic M. Seiwerth S. Stable gastric pentadecapeptide BPC 157 as useful cytoprotective peptide therapy in the heart disturbances, myocardial infarction, heart failure, pulmonary hypertension, arrhythmias, and thrombosis presentation. Biomedicines 2022 10 11 2696 10.3390/biomedicines10112696 36359218
    [Google Scholar]
  6. Sikiric P. Skrtic A. Gojkovic S. Krezic I. Zizek H. Lovric E. Sikiric S. Knezevic M. Strbe S. Milavic M. Kokot A. Blagaic A.B. Seiwerth S. Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome. World J. Gastroenterol. 2022 28 1 23 46 10.3748/wjg.v28.i1.23 35125818
    [Google Scholar]
  7. Sikiric P. Sever M. Krezic I. Vranes H. Kalogjera L. Smoday I.M. Vukovic V. Oroz K. Coric L. Skoro M. Kavelj I. Zubcic S. Sikiric S. Beketic Oreskovic L. Oreskovic I. Blagaic V. Brcic K. Strbe S. Staresinic M. Boban Blagaic A. Skrtic A. Seiwerth S. New studies with stable gastric pentadecapeptide protecting gastrointestinal tract. Significance of counteraction of vascular and multiorgan failure of occlusion/occlusion-like syndrome in cytoprotection/organoprotection. Inflammopharmacology 2024 32 5 3119 3161 10.1007/s10787‑024‑01499‑8 38980576
    [Google Scholar]
  8. Sikiric P. Kokot A. Kralj T. Zlatar M. Masnec S. Lazic R. Loncaric K. Oroz K. Sablic M. Boljesic M. Antunovic M. Sikiric S. Strbe S. Stambolija V. Beketic Oreskovic L. Kavelj I. Novosel L. Zubcic S. Krezic I. Skrtic A. Jurjevic I. Boban Blagaic A. Seiwerth S. Staresinic M. Stable gastric pentadecapeptide BPC 157- Possible novel therapy of glaucoma and other ocular conditions. Pharmaceuticals 2023 16 7 1052 10.3390/ph16071052 37513963
    [Google Scholar]
  9. Vukojevic J. Milavić M. Perović D. Ilić S. Čilić A. Đuran N. Štrbe S. Zoričić Z. Filipčić I. Brečić P. Seiverth S. Sikirić P. Pentadecapeptide BPC 157 and the central nervous system. Neural Regen. Res. 2022 17 3 482 487 10.4103/1673‑5374.320969 34380875
    [Google Scholar]
  10. Park J.M. Lee H.J. Sikiric P. Hahm K.B. BPC 157 rescued NSAID-cytotoxicity via stabilizing intestinal permeability and enhancing cytoprotection. Curr. Pharm. Des. 2020 26 25 2971 2981 10.2174/1381612826666200523180301 32445447
    [Google Scholar]
  11. Seiwerth S. Milavic M. Vukojevic J. Gojkovic S. Krezic I. Vuletic L.B. Pavlov K.H. Petrovic A. Sikiric S. Vranes H. Prtoric A. Zizek H. Durasin T. Dobric I. Staresinic M. Strbe S. Knezevic M. Sola M. Kokot A. Sever M. Lovric E. Skrtic A. Blagaic A.B. Sikiric P. Stable gastric pentadecapeptide BPC 157 and wound healing. Front. Pharmacol. 2021 12 627533 10.3389/fphar.2021.627533 34267654
    [Google Scholar]
  12. Sikiric P. Drmic D. Sever M. Klicek R. Blagaic A.B. Tvrdeic A. Kralj T. Kovac K.K. Vukojevic J. Siroglavic M. Gojkovic S. Krezic I. Pavlov K.H. Rasic D. Mirkovic I. Kokot A. Skrtic A. Seiwerth S. Fistulas healing, stable gastric pentadecapeptide BPC 157 therapy. Curr. Pharm. Des. 2020 26 25 2991 3000 10.2174/1381612826666200424180139 32329684
    [Google Scholar]
  13. Sikiric P. Hahm K.B. Blagaic A.B. Tvrdeic A. Pavlov K.H. Petrovic A. Kokot A. Gojkovic S. Krezic I. Drmic D. Rucman R. Seiwerth S. Stable gastric pentadecapeptide BPC 157, Robert’s stomach cytoprotection/adaptive cytoprotection/organoprotection, and Selye’s stress coping response: Progress, achievements, and the future. Gut Liver 2020 14 2 153 167 10.5009/gnl18490 31158953
    [Google Scholar]
  14. Sikiric P. Drmic D. Boban Blagaic A. Tvrdeic A. Krezic I. Gojkovic S. Zizek H. Sikiric S. Strbe S. Smoday I.M. Lovric E. Skrtic A. Seiwerth S. Stable gastric pentadecapeptide BPC 157 and NO-system. Nitric Oxide: From Research to Therapeutics, Advances in Biochemistry in Health and Disease 22. Ray A. Gulati K. Cham, Switzerland Springer Nature 2023 349 375 10.1007/978‑3‑031‑24778‑1_17
    [Google Scholar]
  15. Gwyer D. Wragg N.M. Wilson S.L. Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing. Cell Tissue Res. 2019 377 2 153 159 10.1007/s00441‑019‑03016‑8 30915550
    [Google Scholar]
  16. Seiwerth S. Rucman R. Turkovic B. Sever M. Klicek R. Radic B. Drmic D. Stupnisek M. Misic M. Vuletic L.B. Pavlov K.H. Barisic I. Kokot A. Japjec M. Blagaic A.B. Tvrdeic A. Rokotov D.S. Vrcic H. Staresinic M. Sebecic B. Sikiric P. BPC 157 and standard angiogenic growth factors. Gastrointesinal tract healing, lessons from tendon, ligament, muscle and bone healing. Curr. Pharm. Des. 2018 24 18 1972 1989 10.2174/1381612824666180712110447 29998800
    [Google Scholar]
  17. Szabo S. Yoshida M. Filakovszky J. Juhasz G. “Stress” is 80 years old: From Hans Selye original paper in 1936 to recent advances in GI ulceration. Curr. Pharm. Des. 2017 23 27 4029 4041 10.2174/1381612823666170622110046 28641541
    [Google Scholar]
  18. Gyires K. Feher A. Stress, neuropeptides and gastric mucosa. Curr. Pharm. Des. 2017 23 27 3928 3940 10.2174/1381612823666161118144216 27855611
    [Google Scholar]
  19. Deek S.A. BPC 157 as potential treatment for COVID-19. Med. Hypotheses 2022 158 110736 10.1016/j.mehy.2021.110736 34798584
    [Google Scholar]
  20. Wood J.D. The first nobel prize for integrated systems physiology: Ivan Petrovich Pavlov, 1904. Physiology 2004 19 6 326 330 10.1152/physiol.00034.2004 15546849
    [Google Scholar]
  21. Kang E.A. Han Y.M. An J.M. Park Y.J. Sikiric P. Kim D.H. Kwon K.A. Kim Y.J. Yang D. Tchah H. Hahm K.B. BPC157 as potential agent rescuing from cancer cachexia. Curr. Pharm. Des. 2018 24 18 1947 1956 10.2174/1381612824666180614082950 29898649
    [Google Scholar]
  22. Sikiric P. Seiwerth S. Rucman R. Drmic D. Stupnisek M. Kokot A. Sever M. Zoricic I. Zoricic Z. Batelja L. Ziger T. Luetic K. Vlainic J. Rasic Z. Bencic M.L. Stress in gastrointestinal tract and stable gastric pentadecapeptide BPC 157. Finally, do we have a solution? Curr. Pharm. Des. 2017 23 27 4012 4028 10.2174/1381612823666170220163219 28228068
    [Google Scholar]
  23. Sikiric P. Seiwerth S. Rucman R. Turkovic B. Rokotov D. Brcic L. Sever M. Klicek R. Radic B. Drmic D. Ilic S. Kolenc D. Aralica G. Stupnisek M. Suran J. Barisic I. Dzidic S. Vrcic H. Sebecic B. Stable gastric pentadecapeptide BPC 157-NO-system relation. Curr. Pharm. Des. 2014 20 7 1126 1135 10.2174/13816128113190990411 23755725
    [Google Scholar]
  24. Sikiric P. Seiwerth S. Rucman R. Turkovic B. Stancic Rokotov D. Brcic L. Sever M. Klicek R. Radic B. Drmic D. Ilic S. Kolenc D. Aralica G. Safic H. Suran J. Rak D. Dzidic S. Vrcic H. Sebecic B. Toxicity by NSAIDs. Counteraction by stable gastric pentadecapeptide BPC 157. Curr. Pharm. Des. 2012 19 1 76 83 10.2174/13816128130111 22950504
    [Google Scholar]
  25. Sikiric P. Seiwerth S. Brcic L. Sever M. Klicek R. Radic B. Drmic D. Ilic S. Kolenc D. Revised Robert’s cytoprotection and adaptive cytoprotection and stable gastric pentadecapeptide BPC 157. Possible significance and implications for novel mediator. Curr. Pharm. Des. 2010 16 10 1224 1234 10.2174/138161210790945977 20166993
    [Google Scholar]
  26. Sikiric P. Seiwerth S. Rucman R. Turkovic B. Stancic Rokotov D. Brcic L. Sever M. Klicek R. Radic B. Drmic D. Ilic S. Kolenc D. Vrcic H. Sebecic B. Stable gastric pentadecapeptide BPC 157: Novel therapy in gastrointestinal tract. Curr. Pharm. Des. 2011 17 16 1612 1632 10.2174/138161211796196954 21548867
    [Google Scholar]
  27. Sikirić P. Petek M. Ručman R. Seiwerth S. Grabarević Z. Rotkvić I. Turković B. Jagić V. Mildner B. Duvnjak M. Lang N. Danilović Z. Cviko A. Kolega M. Sallmani A. Djačić S. Bura M. Brkić T. Banić M. Dodig M. Corić V. Šimičević V. Veljaca M. Erceg D. Ježek D. Simunić-Banek L.J. Skroza N. Bulić K. Buljat G. Hanževački M. Orihovać V. Lučinger D. Culig J. Separović J. Marović A. Miše S. Suchanek E. Matoz W. Perović D. Gjurašin M. Mikulandra S. Derniković K. Cuk V. Karakas I. A new gastric juice peptide, BPC. An overview of the stomach-stress-organoprotection hypothesis and beneficial effects of BPC. J. Physiol. Paris 1993 87 5 313 327 10.1016/0928‑4257(93)90038‑U 8298609
    [Google Scholar]
  28. Xu C. Sun L. Ren F. Huang P. Tian Z. Cui J. Zhang W. Wang S. Zhang K. He L. Zhang W. Zhang C. Hao Q. Zhang Y. Li M. Li W. Preclinical safety evaluation of body protective compound-157, a potential drug for treating various wounds. Regul. Toxicol. Pharmacol. 2020 114 104665 10.1016/j.yrtph.2020.104665 32334036
    [Google Scholar]
  29. Hsieh M.J. Lee C.H. Chueh H.Y. Chang G.J. Huang H.Y. Lin Y. Pang J.H.S. Modulatory effects of BPC 157 on vasomotor tone and the activation of Src-Caveolin-1-endothelial nitric oxide synthase pathway. Sci. Rep. 2020 10 1 17078 10.1038/s41598‑020‑74022‑y 33051481
    [Google Scholar]
  30. Hsieh M.J. Liu H.T. Wang C.N. Huang H.Y. Lin Y. Ko Y.S. Wang J.S. Chang V.H.S. Pang J.H.S. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. J. Mol. Med. 2017 95 3 323 333 10.1007/s00109‑016‑1488‑y 27847966
    [Google Scholar]
  31. Wu H. Wei M. Li N. Lu Q. Shrestha S.M. Tan J. Zhang Z. Wu G. Shi R. Clopidogrel-induced gastric injury in rats is attenuated by stable gastric pentadecapeptide BPC 157. Drug Des. Devel. Ther. 2020 14 5599 5610 10.2147/DDDT.S284163 33376304
    [Google Scholar]
  32. Huang B.S. Huang S.C. Chen F.H. Chang Y. Mei H.F. Huang H.Y. Chen W.Y. Pang J.H.S. Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro. Life Sci. 2022 310 121072 10.1016/j.lfs.2022.121072 36228773
    [Google Scholar]
  33. Huang T. Gu J. Zhang K. Sun L. Xue X. Zhang C. Shu Z. Mu N. Zhang Wang Y. Zhang Y. Zhang W. Body protective compound-157 enhances alkali-burn wound healing in vivo and promotes proliferation, migration, and angiogenesis in vitro. Drug Des. Devel. Ther. 2015 9 2485 2499 10.2147/DDDT.S82030 25995620
    [Google Scholar]
  34. Chang C.H. Tsai W.C. Hsu Y.H. Pang J.H. Pentadecapeptide BPC 157 enhances the growth hormone receptor expression in tendon fibroblasts. Molecules 2014 19 11 19066 19077 10.3390/molecules191119066 25415472
    [Google Scholar]
  35. Chang C.H. Tsai W.C. Lin M.S. Hsu Y.H. Pang J.H.S. The promoting effect of pentadecapeptide BPC 157 on tendon healing involves tendon outgrowth, cell survival, and cell migration. J. Appl. Physiol. 2011 110 3 774 780 10.1152/japplphysiol.00945.2010 21030672
    [Google Scholar]
  36. Wang X.Y. Qu M. Duan R. Shi D. Jin L. Gao J. Wood J.D. Li J. Wang G.D. Cytoprotective mechanism of the novel gastric peptide BPC157 in gastrointestinal tract and cultured enteric neurons and glial cells. Neurosci. Bull. 2019 35 1 167 170 10.1007/s12264‑018‑0269‑8 30116973
    [Google Scholar]
  37. Tkalčević V.I. Čužić S. Brajša K. Mildner B. Bokulić A. Šitum K. Perović D. Glojnarić I. Parnham M.J. Enhancement by PL 14736 of granulation and collagen organization in healing wounds and the potential role of egr-1 expression. Eur. J. Pharmacol. 2007 570 1-3 212 221 10.1016/j.ejphar.2007.05.072 17628536
    [Google Scholar]
  38. Camilleri M. Leaky gut: Mechanisms, measurement and clinical implications in humans. Gut 2019 68 8 1516 1526 10.1136/gutjnl‑2019‑318427 31076401
    [Google Scholar]
  39. Meijers B. Jouret F. Evenepoel P. Linking gut microbiota to cardiovascular disease and hypertension: Lessons from chronic kidney disease. Pharmacol. Res. 2018 133 101 107 10.1016/j.phrs.2018.04.023 29715498
    [Google Scholar]
  40. Obrenovich M.E.M. Leaky gut, leaky brain? Microorganisms 2018 6 4 107 10.3390/microorganisms6040107 30340384
    [Google Scholar]
  41. Anderson G. Seo M. Berk M. Carvalho A. Maes M. Gut permeability and microbiota in Parkinson’s disease: Role of depression, tryptophan catabolites, oxidative and nitrosative stress and melatonergic pathways. Curr. Pharm. Des. 2016 22 40 6142 6151 10.2174/1381612822666160906161513 27604608
    [Google Scholar]
  42. Aleman R.S. Moncada M. Aryana K.J. Leaky gut and the ingredients that help treat it: A review. Molecules 2023 28 2 619 10.3390/molecules28020619 36677677
    [Google Scholar]
  43. Konturek S.J. Role of growth factors in gastroduodenal protection and healing of peptic ulcers. Gastroenterol. Clin. North Am. 1990 19 1 41 65 10.1016/S0889‑8553(21)00456‑8 1970337
    [Google Scholar]
  44. Lau W.L. Kalantar-Zadeh K. Vaziri N.D. The gut as a source of inflammation in chronic kidney disease. Nephron J. 2015 130 2 92 98 10.1159/000381990 25967288
    [Google Scholar]
  45. Fändriks L. Roles of the gut in the metabolic syndrome: An overview. J. Intern. Med. 2017 281 4 319 336 10.1111/joim.12584 27991713
    [Google Scholar]
  46. Li X. Atkinson M.A. The role for gut permeability in the pathogenesis of type 1 diabetes - A solid or leaky concept? Pediatr. Diabetes 2015 16 7 485 492 10.1111/pedi.12305 26269193
    [Google Scholar]
  47. Gupta H. Youn G.S. Shin M.J. Suk K.T. Role of gut microbiota in hepatocarcinogenesis. Microorganisms 2019 7 5 121 10.3390/microorganisms7050121 31060311
    [Google Scholar]
  48. Saggioro A. Leaky gut, microbiota, and cancer: An incoming hypothesis. J. Clin. Gastroenterol. 2014 48 Suppl. 1 S62 S66 10.1097/MCG.0000000000000255 25291131
    [Google Scholar]
  49. Vukojević J. Vrdoljak B. Malekinušić D. Siroglavić M. Milavić M. Kolenc D. Boban Blagaić A. Batelja L. Drmić D. Seiverth S. Sikirić P. The effect of pentadecapeptide BPC 157 on hippocampal ischemia/reperfusion injuries in rats. Brain Behav. 2020 10 8 e01726 10.1002/brb3.1726 32558293
    [Google Scholar]
  50. Vukojević J. Siroglavić M. Kašnik K. Kralj T. Stanćić D. Kokot A. Kolarić D. Drmić D. Sever A.Z. Barišić I. Šuran J. Bojić D. Patrlj M.H. Sjekavica I. Pavlov K.H. Vidović T. Vlainić J. Stupnišek M. Seiwerth S. Sikirić P. Rat inferior caval vein (ICV) ligature and particular new insights with the stable gastric pentadecapeptide BPC 157. Vascul. Pharmacol. 2018 106 54 66 10.1016/j.vph.2018.02.010 29510201
    [Google Scholar]
  51. Knezevic M. Gojkovic S. Krezic I. Zizek H. Vranes H. Malekinusic D. Vrdoljak B. Knezevic T. Horvat Pavlov K. Drmic D. Staroveski M. Djuzel A. Rajkovic Z. Kolak T. Lovric E. Milavic M. Sikiric S. Barisic I. Tepes M. Tvrdeic A. Patrlj L. Strbe S. Sola M. Situm A. Kokot A. Boban Blagaic A. Skrtic A. Seiwerth S. Sikiric P. Complex syndrome of the complete occlusion of the end of the superior mesenteric vein, opposed with the stable gastric pentadecapeptide BPC 157 in rats. Biomedicines 2021 9 8 1029 10.3390/biomedicines9081029 34440233
    [Google Scholar]
  52. Knezevic M. Gojkovic S. Krezic I. Zizek H. Malekinusic D. Vrdoljak B. Knezevic T. Vranes H. Drmic D. Staroveski M. Djuzel A. Rajkovic Z. Kolak T. Lovric E. Milavic M. Sikiric S. Tvrdeic A. Patrlj L. Strbe S. Sola M. Situm A. Kokot A. Boban Blagaic A. Skrtic A. Seiwerth S. Sikiric P. Occluded superior mesenteric artery and vein. Therapy with the stable gastric pentadecapeptide BPC 157. Biomedicines 2021 9 7 792 10.3390/biomedicines9070792 34356860
    [Google Scholar]
  53. Knezevic M. Gojkovic S. Krezic I. Zizek H. Malekinusic D. Vrdoljak B. Vranes H. Knezevic T. Barisic I. Horvat Pavlov K. Drmic D. Staroveski M. Djuzel A. Rajkovic Z. Kolak T. Kocman I. Lovric E. Milavic M. Sikiric S. Tvrdeic A. Patrlj L. Strbe S. Kokot A. Boban Blagaic A. Skrtic A. Seiwerth S. Sikiric P. Occlusion of the superior mesenteric artery in rats reversed by collateral pathways activation: Gastric pentadecapeptide BPC 157 therapy counteracts multiple organ dysfunction syndrome; Intracranial, portal, and caval hypertension; and aortal hypotension. Biomedicines 2021 9 6 609 10.3390/biomedicines9060609 34073625
    [Google Scholar]
  54. Kralj T. Kokot A. Zlatar M. Masnec S. Kasnik Kovac K. Milkovic Perisa M. Batelja Vuletic L. Giljanovic A. Strbe S. Sikiric S. Balog S. Sontacchi B. Sontacchi D. Buljan M. Lovric E. Boban Blagaic A. Skrtic A. Seiwerth S. Sikiric P. Stable gastric pentadecapeptide BPC 157 therapy of rat glaucoma. Biomedicines 2021 10 1 89 10.3390/biomedicines10010089 35052769
    [Google Scholar]
  55. Gojkovic S. Krezic I. Vranes H. Zizek H. Drmic D. Horvat Pavlov K. Petrovic A. Batelja Vuletic L. Milavic M. Sikiric S. Stilinovic I. Samara M. Knezevic M. Barisic I. Sjekavica I. Lovric E. Skrtic A. Seiwerth S. Sikiric P. BPC 157 therapy and permanent occlusion of the superior sagittal sinus in rat: Vascular recruitment. Biomedicines 2021 9 7 744 10.3390/biomedicines9070744 34203464
    [Google Scholar]
  56. Tepes M. Gojkovic S. Krezic I. Zizek H. Vranes H. Madzar Z. Santak G. Batelja L. Milavic M. Sikiric S. Kocman I. Simonji K. Samara M. Knezevic M. Barisic I. Lovric E. Strbe S. Kokot A. Sjekavica I. Kolak T. Skrtic A. Seiwerth S. Boban Blagaic A. Sikiric P. Stable gastric pentadecapeptide BPC 157 therapy for primary abdominal compartment syndrome in rats. Front. Pharmacol. 2021 12 718147 10.3389/fphar.2021.718147 34966273
    [Google Scholar]
  57. Tepes M. Krezic I. Vranes H. Smoday I.M. Kalogjera L. Zizek H. Vukovic V. Oroz K. Kovac K.K. Madzar Z. Rakic M. Miskic B. Sikiric S. Barisic I. Strbe S. Antunovic M. Novosel L. Kavelj I. Vlainic J. Dobric I. Staresinic M. Skrtic A. Seiwerth S. Blagaic A.B. Sikiric P. Stable gastric pentadecapeptide BPC 157 therapy: Effect of reperfusion following maintained intra-abdominal hypertension (grade III and IV) in rats. Pharmaceuticals 2023 16 11 1554 10.3390/ph16111554 38004420
    [Google Scholar]
  58. Smoday I.M. Petrovic I. Kalogjera L. Vranes H. Zizek H. Krezic I. Gojkovic S. Skorak I. Hriberski K. Brizic I. Kubat M. Strbe S. Barisic I. Sola M. Lovric E. Lozic M. Boban Blagaic A. Skrtic A. Seiwerth S. Sikiric P. Therapy effect of the stable gastric pentadecapeptide BPC 157 on acute pancreatitis as vascular failure-induced severe peripheral and central syndrome in rats. Biomedicines 2022 10 6 1299 10.3390/biomedicines10061299 35740321
    [Google Scholar]
  59. Kalogjera L. Krezic I. Smoday I.M. Vranes H. Zizek H. Yago H. Oroz K. Vukovic V. Kavelj I. Novosel L. Zubcic S. Barisic I. Beketic Oreskovic L. Strbe S. Sever M. Sjekavica I. Skrtic A. Boban Blagaic A. Seiwerth S. Sikiric P. Stomach perforation-induced general occlusion/occlusion-like syndrome and stable gastric pentadecapeptide BPC 157 therapy effect. World J. Gastroenterol. 2023 29 27 4289 4316 10.3748/wjg.v29.i27.4289 37545637
    [Google Scholar]
  60. Gojkovic S. Krezic I. Vranes H. Zizek H. Drmic D. Batelja Vuletic L. Milavic M. Sikiric S. Stilinovic I. Simeon P. Knezevic M. Kolak T. Tepes M. Simonji K. Strbe S. Nikolac Gabaj N. Barisic I. Oreskovic E.G. Lovric E. Kokot A. Skrtic A. Boban Blagaic A. Seiwerth S. Sikiric P. Robert’s intragastric alcohol-induced gastric lesion model as an escalated general peripheral and central syndrome, counteracted by the stable gastric pentadecapeptide BPC 157. Biomedicines 2021 9 10 1300 10.3390/biomedicines9101300 34680419
    [Google Scholar]
  61. Barisic I. Balenovic D. Udovicic M. Bardak D. Strinic D. Vlainić J. Vranes H. Smoday I.M. Krezic I. Milavic M. Sikiric S. Uzun S. Zivanovic Posilovic G. Strbe S. Vukoja I. Lovric E. Lozic M. Sever M. Lovric Bencic M. Boban Blagaic A. Skrtic A. Seiwerth S. Sikiric P. Stable gastric pentadecapeptide BPC 157 may counteract myocardial infarction induced by isoprenaline in rats. Biomedicines 2022 10 2 265 10.3390/biomedicines10020265 35203478
    [Google Scholar]
  62. Smoday I.M. Krezic I. Kalogjera L. Vukovic V. Zizek H. Skoro M. Kovac K.K. Vranes H. Barisic I. Sikiric S. Strbe S. Tepes M. Oroz K. Zubcic S. Stupnisek M. Beketic Oreskovic L. Kavelj I. Novosel L. Prenc M. Barsic Ostojic S. Dobric I. Sever M. Blagaic A.B. Skrtic A. Staresinic M. Sjekavica I. Seiwerth S. Sikiric P. Pentadecapeptide BPC 157 as therapy for inferior caval vein embolization: Recovery of sodium laurate-post-embolization syndrome in rats. Pharmaceuticals 2023 16 10 1507 10.3390/ph16101507 37895979
    [Google Scholar]
  63. Premuzic Mestrovic I. Smoday I.M. Kalogjera L. Krezic I. Zizek H. Vranes H. Vukovic V. Oroz K. Skorak I. Brizic I. Hriberski K. Novosel L. Kavelj I. Barisic I. Beketic Oreskovic L. Zubcic S. Strbe S. Mestrovic T. Pavic P. Staresinic M. Skrtic A. Boban Blagaic A. Seiwerth S. Sikiric P. Antiarrhythmic sotalol, occlusion/occlusion-like syndrome in rats, and stable gastric pentadecapeptide BPC 157 therapy. Pharmaceuticals 2023 16 7 977 10.3390/ph16070977 37513889
    [Google Scholar]
  64. Strbe S. Smoday I.M. Krezic I. Kalogjera L. Vukovic V. Zizek H. Gojkovic S. Vranes H. Barisic I. Sikiric S. Tepes M. Oroz K. Brkic F. Drinkovic M. Beketic Oreskovic L. Popic J. Boban Blagaic A. Skrtic A. Staresinic M. Seiwerth S. Sikiric P. Innate vascular failure by application of neuroleptics, amphetamine, and domperidone rapidly induced severe occlusion/occlusion-like syndrome in rats and stable gastric pentadecapeptide BPC 157 as therapy. Pharmaceuticals 2023 16 6 788 10.3390/ph16060788 37375736
    [Google Scholar]
  65. Strbe S. Gojkovic S. Krezic I. Zizek H. Vranes H. Barisic I. Strinic D. Orct T. Vukojevic J. Ilic S. Lovric E. Muzinic D. Kolenc D. Filipčić I. Zoricic Z. Marcinko D. Boban Blagaic A. Skrtic A. Seiwerth S. Sikiric P. Over-dose lithium toxicity as an occlusive-like syndrome in rats and gastric pentadecapeptide BPC 157. Biomedicines 2021 9 11 1506 10.3390/biomedicines9111506 34829735
    [Google Scholar]
  66. Barisic I. Balenovic D. Klicek R. Radic B. Nikitovic B. Drmic D. Udovicic M. Strinic D. Bardak D. Berkopic L. Djuzel V. Sever M. Cvjetko I. Romic Z. Sindic A. Bencic M.L. Seiwerth S. Sikiric P. Mortal hyperkalemia disturbances in rats are NO-system related. The life saving effect of pentadecapeptide BPC 157. Regul. Pept. 2013 181 50 66 10.1016/j.regpep.2012.12.007 23327997
    [Google Scholar]
  67. Stambolija V. Stambolija T.P. Holjevac J.K. Murselovic T. Radonic J. Duzel V. Duplancic B. Uzun S. Zivanovic-Posilovic G. Kolenc D. Drmic D. Romic Z. Seiwerth S. Sikiric P. BPC 157: The counteraction of succinylcholine, hyperkalemia, and arrhythmias. Eur. J. Pharmacol. 2016 781 83 91 10.1016/j.ejphar.2016.04.004 27060013
    [Google Scholar]
  68. Medvidovic-Grubisic M. Stambolija V. Kolenc D. Katancic J. Murselovic T. Plestina-Borjan I. Strbe S. Drmic D. Barisic I. Sindic A. Seiwerth S. Sikiric P. Hypermagnesemia disturbances in rats, NO-related: Pentadecapeptide BPC 157 abrogates, l-NAME and l-arginine worsen. Inflammopharmacology 2017 25 4 439 449 10.1007/s10787‑017‑0323‑6 28210905
    [Google Scholar]
  69. Balenovic D. Barisic I. Prkacin I. Horvat I. Udovicic M. Uzun S. Strinic D. Pevec D. Drmic D. Radic B. Bardak D. Zlatar M. Aralica G. Lovric Bencic M. Separovic Hanzevacki J. Romic Z. Sindic A. Seiwerth S. Sikiric P. Mortal furosemide-hypokalemia-disturbances in rats NO-system related. Shorten survival by L-NAME. Therapy benefit with BPC 157 peptide more than with L-arginine. J. Clin. Exp. Cardiolog. 2012 3 7 201 10.4172/2155‑9880.1000201
    [Google Scholar]
  70. Aal-Hamad A.H. Al-Alawi A.M. Kashoub M.S. Falhammar H. Hypermagnesemia in clinical practice. Medicina 2023 59 7 1190 10.3390/medicina59071190 37512002
    [Google Scholar]
  71. Clausen T. Hormonal and pharmacological modification of plasma potassium homeostasis. Fundam. Clin. Pharmacol. 2010 24 5 595 605 10.1111/j.1472‑8206.2010.00859.x 20618871
    [Google Scholar]
  72. Elliott M.J. Ronksley P.E. Clase C.M. Ahmed S.B. Hemmelgarn B.R. Management of patients with acute hyperkalemia. CMAJ 2010 182 15 1631 1635 10.1503/cmaj.100461 20855477
    [Google Scholar]
  73. Soar J. Perkins G.D. Abbas G. Alfonzo A. Barelli A. Bierens J.J.L.M. Brugger H. Deakin C.D. Dunning J. Georgiou M. Handley A.J. Lockey D.J. Paal P. Sandroni C. Thies K.C. Zideman D.A. Nolan J.P. European resuscitation council guidelines for resuscitation 2010 section 8. Cardiac arrest in special circumstances: Electrolyte abnormalities, poisoning, drowning, accidental hypothermia, hyperthermia, asthma, anaphylaxis, cardiac surgery, trauma, pregnancy, electrocution. Resuscitation 2010 81 10 1400 1433 10.1016/j.resuscitation.2010.08.015 20956045
    [Google Scholar]
  74. Jope R.S. Nemeroff C.B. Lithium to the rescue. Cerebrum 2016 2016 cer-02 cer-16 27408673
    [Google Scholar]
  75. Robert A. Cytoprotection by prostaglandins. Gastroenterology 1979 77 4 761 767 10.1016/0016‑5085(79)90235‑X 38173
    [Google Scholar]
  76. Szabo S. Trier J.S. Brown A. Schnoor J. Early vascular injury and increased vascular permeability in gastric mucosal injury caused by ethanol in the rat. Gastroenterology 1985 88 1 228 236 10.1016/S0016‑5085(85)80176‑1 3871087
    [Google Scholar]
  77. Szabo S. Usadel K.H. Cytoprotection-organoprotection by somatostatin: Gastric and hepatic lesions. Experientia 1982 38 2 254 256 10.1007/BF01945097 6120852
    [Google Scholar]
  78. Walker F.O. Scott G.E. Butterworth J. Sustained focal effects of low‐dose intramuscular succinylcholine. Muscle Nerve 1993 16 2 181 187 10.1002/mus.880160211 8429843
    [Google Scholar]
  79. Perry J.J. Lee J.S. Sillberg V.A. Wells G.A. Rocuronium versus succinylcholine for rapid sequence induction intubation. Cochrane Database Syst. Rev. 2008 2 2 CD002788 10.1002/14651858.CD002788.pub2 18425883
    [Google Scholar]
  80. Martyn J.A.J. Richtsfeld M. Warner D.O. Succinylcholine-induced hyperkalemia in acquired pathologic states: Etiologic factors and molecular mechanisms. Anesthesiology 2006 104 1 158 169 10.1097/00000542‑200601000‑00022 16394702
    [Google Scholar]
  81. Bartolone R.S. Rao T.L.K. Dysrhythmias following muscle relaxant administration in patients receiving digitalis. Anesthesiology 1983 58 6 567 568 10.1097/00000542‑198306000‑00017 6222678
    [Google Scholar]
  82. Hrelec M. Klicek R. Brcic L. Brcic I. Cvjetko I. Seiwerth S. Sikiric P. Abdominal aorta anastomosis in rats and stable gastric pentadecapeptide BPC 157, prophylaxis and therapy. J. Physiol. Pharmacol. 2009 60 Suppl. 7 161 165 20388960
    [Google Scholar]
  83. Perovic D. Kolenc D. Bilic V. Somun N. Drmic D. Elabjer E. Buljat G. Seiwerth S. Sikiric P. Stable gastric pentadecapeptide BPC 157 can improve the healing course of spinal cord injury and lead to functional recovery in rats. J. Orthop. Surg. Res. 2019 14 1 199 10.1186/s13018‑019‑1242‑6 31266512
    [Google Scholar]
  84. Perovic D. Milavic M. Dokuzovic S. Krezic I. Gojkovic S. Vranes H. Bebek I. Bilic V. Somun N. Brizic I. Skorak I. Hriberski K. Sikiric S. Lovric E. Strbe S. Kubat M. Boban Blagaic A. Skrtic A. Seiwerth S. Sikiric P. Novel therapeutic effects in rat spinal cord injuries: Recovery of the definitive and early spinal cord injury by the administration of pentadecapeptide BPC 157 therapy. Curr. Issues Mol. Biol. 2022 44 5 1901 1927 10.3390/cimb44050130 35678659
    [Google Scholar]
  85. Tudor M. Jandric I. Marovic A. Gjurasin M. Perovic D. Radic B. Blagaic A.B. Kolenc D. Brcic L. Zarkovic K. Seiwerth S. Sikiric P. Traumatic brain injury in mice and pentadecapeptide BPC 157 effect. Regul. Pept. 2010 160 1-3 26 32 10.1016/j.regpep.2009.11.012 19931318
    [Google Scholar]
  86. Klicek R. Kolenc D. Suran J. Drmic D. Brcic L. Aralica G. Sever M. Holjevac J. Radic B. Turudic T. Kokot A. Patrlj L. Rucman R. Seiwerth S. Sikiric P. Stable gastric pentadecapeptide BPC 157 heals cysteamine-colitis and colon-colon-anastomosis and counteracts cuprizone brain injuries and motor disability. J. Physiol. Pharmacol. 2013 64 5 597 612 24304574
    [Google Scholar]
  87. Sikiric P. Marovic A. Matoz W. Anic T. Buljat G. Mikus D. Stancic-Rokotov D. Šeparovic J. Seiwerth S. Grabarevic Z. Rucman R. Petek M. Ziger T. Sebecic B. Zoricic I. Turkovic B. Aralica G. Perovic D. Duplancic B. Lovric-Bencic M. Rotkvic I. Mise S. Jagic V. Hahn V. A behavioural study of the effect of pentadecapeptide BPC 157 in Parkinson’s disease models in mice and gastric lesions induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. J. Physiol. Paris 1999 93 6 505 512 10.1016/S0928‑4257(99)00119‑9 10672997
    [Google Scholar]
  88. Jelovac N. Sikiric P. Rucman R. Petek M. Marovic A. Perovic D. Seiwerth S. Mise S. Turkovic B. Dodig G. Miklic P. Buljat G. Prkacin I. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: The effect on catalepsy and gastric ulcers in mice and rats. Eur. J. Pharmacol. 1999 379 1 19 31 10.1016/S0014‑2999(99)00486‑0 10499368
    [Google Scholar]
  89. Zemba Cilic A. Zemba M. Cilic M. Balenovic I. Strbe S. Ilic S. Vukojevic J. Zoricic Z. Filipcic I. Kokot A. Drmic D. Blagaic A.B. Tvrdeic A. Seiwerth S. Sikiric P. Pentadecapeptide BPC 157 counteracts L-NAME-induced catalepsy. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat acute and chronic models resembling ‘positive-like’ symptoms of schizophrenia. Behav. Brain Res. 2021 396 112919 10.1016/j.bbr.2020.112919 32956773
    [Google Scholar]
  90. Blagaic A.B. Blagaic V. Romic Z. Sikiric P. The influence of gastric pentadecapeptide BPC 157 on acute and chronic ethanol administration in mice. Eur. J. Pharmacol. 2004 499 3 285 290 10.1016/j.ejphar.2004.07.112 15381050
    [Google Scholar]
  91. Boban Blagaic A. Blagaic V. Mirt M. Jelovac N. Dodig G. Rucman R. Petek M. Turkovic B. Anic T. Dubovecak M. Staresinic M. Seiwerth S. Sikiric P. Gastric pentadecapeptide BPC 157 effective against serotonin syndrome in rats. Eur. J. Pharmacol. 2005 512 2-3 173 179 10.1016/j.ejphar.2005.02.033 15840402
    [Google Scholar]
  92. Simons P. Nadra I. McNally P.G. Metabolic alkalosis and myoclonus. Postgrad. Med. J. 2003 79 933 414 415 10.1136/pmj.79.933.414 12897223
    [Google Scholar]
  93. Lozic M. Stambolija V. Krezic I. Dugandzic A. Zivanovic-Posilovic G. Gojkovic S. Kovacevic J. Vrdoljak L. Mirkovic I. Kokot A. Petrovic A. Pavlov K.H. Drmic D. Suran J. Blagaic A.B. Seiwerth S. Sikiric P. In relation to NO-system, stable pentadecapeptide BPC 157 counteracts lidocaine-induced adverse effects in rats and depolarisation in vitro. Emerg. Med. Int. 2020 2020 1 20 10.1155/2020/6805354 32566305
    [Google Scholar]
  94. Zivanovic-Posilovic G. Balenovic D. Barisic I. Strinic D. Stambolija V. Udovicic M. Uzun S. Drmic D. Vlainic J. Bencic M.L. Sindic A. Seiwerth S. Sikiric P. Stable gastric pentadecapeptide BPC 157 and bupivacaine. Eur. J. Pharmacol. 2016 793 56 65 10.1016/j.ejphar.2016.10.035 27815173
    [Google Scholar]
  95. Mirković I. Kralj T. Lozić M. Stambolija V. Kovačević J. Vrdoljak L. Zlatar M. Milanović K. Drmić D. Predović J. Masnec S. Jurjević M. Bušić M. Seiwerth S. Kokot A. Sikirić P. Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats. Acta Clin. Croat. 2020 59 3 394 406 10.20471/acc.2020.59.03.02 34177048
    [Google Scholar]
  96. Hermanns H. Hollmann M.W. Stevens M.F. Lirk P. Brandenburger T. Piegeler T. Werdehausen R. Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: A narrative review. Br. J. Anaesth. 2019 123 3 335 349 10.1016/j.bja.2019.06.014 31303268
    [Google Scholar]
  97. Fozzard H.A. Sheets M.F. Hanck D.A. The sodium channel as a target for local anesthetic drugs. Front. Pharmacol. 2011 2 68 10.3389/fphar.2011.00068 22053156
    [Google Scholar]
  98. Bolotina V.M. Najibi S. Palacino J.J. Pagano P.J. Cohen R.A. Nitric oxide directly activates calcium-dependent potassium channels in vascular smooth muscle. Nature 1994 368 6474 850 853 10.1038/368850a0 7512692
    [Google Scholar]
  99. Moncada S. Palmer R.M. Higgs E.A. Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol. Rev. 1991 43 2 109 142 1852778
    [Google Scholar]
  100. Mustafa A.K. Gadalla M.M. Snyder S.H. Signaling by Gasotransmitters. Sci. Signal. 2009 2 68 re2 10.1126/scisignal.268re2 19401594
    [Google Scholar]
  101. Pitsikas N. The role of nitric oxide synthase inhibitors in schizophrenia. Curr. Med. Chem. 2016 23 24 2692 2705 10.2174/0929867323666160812151054 27776474
    [Google Scholar]
  102. Koçyiğit Y. Yoca G. Karahan S. Ayhan Y. Yazici M.K. L-arginine add-on treatment for schizophrenia: A randomized, double-blind, placebo-controlled, crossover study. Turk Psikiyatr. Derg. 2017 29 3 147 153 10.5080/u22702 30260460
    [Google Scholar]
  103. Çelik T. Zaglí U. Kayír H. Uzbay I.T. Nitric oxide synthase inhibition blocks amphetamine-induced locomotor activity in mice. Drug Alcohol Depend. 1999 56 2 109 113 10.1016/S0376‑8716(99)00031‑9 10482402
    [Google Scholar]
  104. Zemba Cilic A. Zemba M. Cilic M. Strbe S. Ilic S. Vukojevic J. Zoricic Z. Filipcic I. Kokot A. Smoday I.M. Rukavina I. Boban Blagaic A. Tvrdeic A. Duplancic B. Stambolija V. Marcinko D. Skrtic A. Seiwerth S. Sikiric P. BPC 157, L-NAME, L-arginine, NO-relation, in the suited rat ketamine models resembling “negative-like” symptoms of schizophrenia. Biomedicines 2022 10 7 1462 10.3390/biomedicines10071462 35884767
    [Google Scholar]
  105. Duzel A. Vlainic J. Antunovic M. Malekinusic D. Vrdoljak B. Samara M. Gojkovic S. Krezic I. Vidovic T. Bilic Z. Knezevic M. Sever M. Lojo N. Kokot A. Kolovrat M. Drmic D. Vukojevic J. Kralj T. Kasnik K. Siroglavic M. Seiwerth S. Sikiric P. Stable gastric pentadecapeptide BPC 157 in the treatment of colitis and ischemia and reperfusion in rats: New insights. World J. Gastroenterol. 2017 23 48 8465 8488 10.3748/wjg.v23.i48.8465 29358856
    [Google Scholar]
  106. Amic F. Drmic D. Bilic Z. Krezic I. Zizek H. Peklic M. Klicek R. Pajtak A. Amic E. Vidovic T. Rakic M. Perisa M.M. Pavlov K.H. Kokot A. Tvrdeic A. Blagaic A.B. Zovak M. Seiwerth S. Sikiric P. Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157, L-NAME and L-arginine. World J. Gastroenterol. 2018 24 47 5366 5378 10.3748/wjg.v24.i47.5366 30598581
    [Google Scholar]
  107. Drmic D. Samara M. Vidovic T. Malekinusic D. Antunovic M. Vrdoljak B. Ruzman J. Perisa M.M. Pavlov K.H. Jeyakumar J. Seiwerth S. Sikiric P. Counteraction of perforated cecum lesions in rats: Effects of pentadecapeptide BPC 157, L-NAME and L-arginine. World J. Gastroenterol. 2018 24 48 5462 5476 10.3748/wjg.v24.i48.5462 30622376
    [Google Scholar]
  108. Kokot A. Zlatar M. Stupnisek M. Drmic D. Radic R. Vcev A. Seiwerth S. Sikiric P. NO system dependence of atropine-induced mydriasis and L-NAME- and L-arginine-induced miosis: Reversal by the pentadecapeptide BPC 157 in rats and guinea pigs. Eur. J. Pharmacol. 2016 771 211 219 10.1016/j.ejphar.2015.12.016 26698393
    [Google Scholar]
  109. Sikirić P. Seiwerth S. Grabarević Ž. Ručman R. Petek M. Jagić V. Turković B. Rotkvić I. Miše S. Zoričić I. Konjevoda P. Perović D. Jurina L. Šeparović J. Hanževački M. Branka Artuković Bratulić M. Tišljar M. Gjurašin M. Miklić P. Stančić-Rokotov D. Slobodnjak Z. Jelovac N. Marović A. The influence of a novel pentadecapeptide, BPC 157, on NG-nitro-l-arginine methylester and l-arginine effects on stomach mucosa integrity and blood pressure. Eur. J. Pharmacol. 1997 332 1 23 33 10.1016/S0014‑2999(97)01033‑9 9298922
    [Google Scholar]
  110. Turkovic B. Sikiric P. Seiwerth S. Mise S. Anic T. Petek M. Stable gastric pentadecapeptide BPC 157 studied for inflammatory bowel disease (PLD-116, PL14736, Pliva) induces nitric oxide synthesis. Gastroenterology 2004 126 287
    [Google Scholar]
  111. Stupnisek M. Kokot A. Drmic D. Hrelec Patrlj M. Zenko Sever A. Kolenc D. Radic B. Suran J. Bojic D. Vcev A. Seiwerth S. Sikiric P. Pentadecapeptide BPC 157 reduces bleeding and thrombocytopenia after amputation in rats treated with heparin, warfarin, L-NAME and L-arginine. PLoS One 2015 10 4 e0123454 10.1371/journal.pone.0123454 25897838
    [Google Scholar]
  112. Gamulin O. Oroz K. Coric L. Krajacic M. Skrabic M. Dretar V. Strbe S. Talapko J. Juzbasic M. Krezic I. Lozic M. Stambolija V. Zizek H. Jurca I. Jurjevic I. Blagaic A.B. Skrtic A. Seiwerth S. Sikiric P. Fourier transform infrared spectroscopy reveals molecular changes in blood vessels of rats treated with pentadecapeptide BPC 157. Biomedicines 2022 10 12 3130 10.3390/biomedicines10123130 36551886
    [Google Scholar]
  113. O’Donnell K.C. Gould T.D. The behavioral actions of lithium in rodent models: Leads to develop novel therapeutics. Neurosci. Biobehav. Rev. 2007 31 6 932 962 10.1016/j.neubiorev.2007.04.002 17532044
    [Google Scholar]
  114. Bosche B. Molcanyi M. Noll T. Rej S. Zatschler B. Doeppner T.R. Hescheler J. Müller D.J. Macdonald R.L. Härtel F.V. A differential impact of lithium on endothelium-dependent but not on endothelium-independent vessel relaxation. Prog. Neuropsychopharmacol. Biol. Psychiatry 2016 67 98 106 10.1016/j.pnpbp.2016.02.004 26875501
    [Google Scholar]
  115. Grabarevic Z. Tisljar M. Artukovic B. Bratulic M. Dzaja P. Seiwerth S. Sikiric P. Peric J. Geres D. Kos J. The influence of BPC 157 on nitric oxide agonist and antagonist induced lesions in broiler chicks. J. Physiol. Paris 1997 91 3-5 139 149 10.1016/S0928‑4257(97)89478‑8 9403788
    [Google Scholar]
  116. Tlak Gajger I. Smodiš Škerl M.I. Šoštarić P. Šuran J. Sikirić P. Vlainić J. Physiological and immunological status of adult honeybees (Apis mellifera) fed sugar syrup supplemented with pentadecapeptide BPC 157. Biology 2021 10 9 891 10.3390/biology10090891 34571768
    [Google Scholar]
  117. Tlak Gajger I. Ribarić J. Smodiš Škerl M. Vlainić J. Sikirić P. Stable gastric pentadecapeptide BPC 157 in honeybee ( Apis mellifera ) therapy, to control Nosema ceranae invasions in apiary conditions. J. Vet. Pharmacol. Ther. 2018 41 4 614 621 10.1111/jvp.12509 29682749
    [Google Scholar]
  118. Filosevic A. Andretic Waldowski R. Sikiric P. Drmic D. Stable gastric pentadecapeptide BPC 157 antagonizes hydrogen peroxide induced oxidative stress in Drosophila melanogaster. FASEB J. 2018 31 Suppl. 1 667.14 10.1096/fasebj.31.1_supplement.667.14
    [Google Scholar]
/content/journals/cn/10.2174/011570159X349612241205065330
Loading
Stable Gastric Pentadecapeptide BPC 157 as a Therapy of Severe Electrolyte Disturbances in Rats
Bentham Science Publishers ; https://doi.org/10.2174/011570159X349612241205065330
/content/journals/cn/10.2174/011570159X349612241205065330
/content/journals/cn/10.2174/011570159X349612241205065330
Loading

Data & Media loading...


  • Article Type:     Review Article
Keywords: serotonin syndrome ; GABA-ergic ; ADHD ; nitric oxide

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test